Latest revenue
$199
as of 2025-09-30
Latest net income
$-2.1M
as of 2025-09-30
Net margin
-1043272.9%
as of 2025-09-30
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $26.4M
- Enterprise value
- $26.4M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $0.00
- 52-wk low
- $0.00
- Beta
- —
- Shares out
- 527.16B
5-year trend
What this company does
Item 1. Business. Healthier Choices Management Corp. (the “Company” or “HCMC”) is focused on marketing its current product offerings, including its patented Q-Cup and Imitine. HCMC also will continue to seek to monetize its intellectual property through royalty and licensing agreements, facilitated by its wholly owned subsidiary, HCMC Intellectual Property Holdings, LLC. HCMC’s IP portfolio includes patents related to innovative products, such as the Q-Cup and Imitine. The Company administers and intends to augment its intellectual property portfolio via its wholly owned subsidiary, HCMC Intellectual Property Holdings, LLC. The Company continues to promote its patented Q-Cup™ technology…
AI summary unavailable — showing raw filing excerpt
Generated from HCMC's filing dated 2026-03-27
Key risks
Item 1A. Risk Factors. Not applicable to smaller reporting companies. Please see the Company’s risk factors contained under Item 7.
AI summary unavailable — showing raw filing excerpt
Generated from HCMC's filing dated 2026-03-27
Profitability
Gross margin
-80.4%
52.8%Operating margin
-20243.9%
200.0%Net margin
-20200.8%
114.1%Return on equity
568.9%
25.3%Return on assets
-478.1%
10.7%Leverage
Debt / equity
-2.19×
9.6%Long-term debt / equity
0.36×
202.2%Debt / assets
184.0%
8.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-786.8K | +64.0% | — |
Q4 2025 2025-12-31 | $31.8K | -74.7% | $-766.4K | +64.8% | -2412.8% |
Q3 2025 2025-09-30 | $199 | +282.7% | $-2.1M | +52.2% | -1043272.9% |
Q2 2025 2025-06-30 | $1.0K | +474.7% | $-2.0M | +20.5% | -199179.7% |
Q1 2025 2025-03-31 | $1.8K | +1395.8% | $-2.2M | +23.7% | -122678.4% |
Q4 2024 2024-12-31 | $125.7K | — | $-2.2M | — | -1731.7% |
Q3 2024 2024-09-30 | $52 | +33.3% | $-4.3M | -45.3% | -8359675.0% |
Q2 2024 2024-06-30 | $174 | -100.0% | $-2.5M | +5.5% | -1440619.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Tobacco Products · SIC 2100
Your notes
Keep private notes on HCMC — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for HCMC in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns HCMC
Institutional value
$1
Total shares held
1.7M
Distinct holders
5
-1 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | CHICAGO TRUST Co NA | 1.0M | $1 | +0 (+0.0%) | No change |
| 2 | NBT BANK N A /NY | 500.0K | $0 | +500.0K | New |
| 3 | PROATHLETE WEALTH MANAGEMENT LLC | 50.0K | $0 | +0 (+0.0%) | No change |
| 4 | MassMutual Private Wealth & Trust, FSB | 12.0K | $0 | +0 (+0.0%) | No change |
| 5 | Wealth Group Ltd | 170.0K | $0 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once HCMC's latest filing finishes processing.